ROP: enfermedad plus

Salud Global y enfermedad cardiovascular

Alma nac 2014: las Re vis tas de las So cie da des Na cio na les pre sen tan in ves ti ga cio nes se lec cio na das que han de ter mi na do re cien tes avan ces en la cardiología clínica Salud Global y enfermedad cardiovascular Bruno R Nascimento1,2,3, Luisa C C Brant1, Diego N Moraes1, Antonio L P Ribeiro1,3 Este ar tícu lo fue pu bli ca do en Heart 2014;100:1743-1749 doi:10.1136/heartjnl-2014...

Enfermedad cardiovascular en el anciano

The aging of the population worldwide will result in increasing numbers of elderly patients, among whom heart disease is the leading cause of death. Changes in cardiovascular physiology with normal aging and prevalent comorbidities result in differences in the effects of common cardiac problems as well as the response to their treatments. Patient-centered goals of care such as maintenance of in...

Enfermedad cardiovascular y grasas: “amigo o villano”

Dietary fatty acids and cholesterol are the main determinants of cardiovascular disease. In the last 25 years our traditional dietary pattern has tended to include higher total fat content and lower nutritional quality, which will have negative effects on our state of health. In this review, we provide an overview of current knowledge on the influence of different dietary fatty acids and choles...

Fosforilación de tau y enfermedad de Alzheimer

Will the BEAT-ROP study results really beat ROP?

Recently, many scientific journals have published articles regarding the role of intravitreal injection of anti-vascular endothelial growth factor (VEGF) in retinopathy of prematurity (ROP). The BEAT-ROP cooperative group have now reported their results. By far, their study seems to be the largest and best executed. In addition, the results are no less than spectacular, and if they can be repea...